Table 2 Comparison of the groups according to the medications used and comorbid diseases
18–64 years (group 1, n = 85) n (%) | ≥ 65 years (group 2, n = 89) n (%) | Test statistics | P | ||
|---|---|---|---|---|---|
Corticosteroids | 8 (9.4) | 7 (7.9) | χ2= 85.882 | < 0.001 | |
NSAIDs | 56 (65.9) | 46 (51.7) | |||
DMARDS | 39 (45.9) | 27 (30.3) | |||
Medicationsused | Biological drugs | 50 (58.8) | 55 (61.8) | ||
Medications for comorbid diseases (nonrheumatic treatments) | 23 (27.1) | 79 (88.8) | |||
Colchicine | 7 (8.2) | 14 (15.7) | |||
Azothiopurine | 2 (2.4) | 2 (2.2) | |||
Allopurinol | 0 (0) | 7 (7.9) | |||
Hypertension | 15 (78.9) | 61 (77.2) | χ2 = 15.515 | 0.008 | |
Diabetes mellitus | 5 (26.3) | 35 (44.3) | |||
Comorbid diseases | Coronary artery disease | 1 (5.3) | 16 (20.3) | ||
Osteoporosis | 2 (10.5) | 23 (29.1) | |||
Psoriasis | 3 (15.8) | 1 (1.3) |